Gene test may unlock hypnosis power for pain relief

NCT ID NCT04624880

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a genetic marker called COMT can predict how well a person responds to hypnosis for pain after surgery. Researchers tested a new, faster method to read this gene from saliva or blood samples. The goal is to one day use a simple genetic test to personalize pain management and reduce the need for opioids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC PREDISPOSITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stanford University/Stanford Healthcare

    Palo Alto, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.